Aino Telaranta-Keerie
Senior Director, Global Precision Medicine Lead Astellas Pharma
Seminars
Tuesday 31st March 2026
Enabling Pharma Compliance with IVDR for Precision Medicine Trials
5:20 pm
- How can pharma build IVDR capabilities to effectively deliver precision medicine trials in the EU?
- How to achieve IVDR compliance for trials with or without diagnostic company involvement?
- How to enable smooth collaboration between pharma, IVD manufacturer and/or CRO(s) for National Competent Authority submissions and approvals?
